InvestorsHub Logo
Followers 1084
Posts 142881
Boards Moderated 5
Alias Born 01/25/2009

Re: None

Wednesday, 08/05/2009 9:08:27 PM

Wednesday, August 05, 2009 9:08:27 PM

Post# of 34627
08/05/09 -- TapImmune Inc. (OTCBB: TPIV), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announces the acquisition of three follow-on inventions and IP relating to its key TAP technology from The University of British Columbia.

This is the start of a run of inventions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News